AlignCare AI CAIHL draft report

AlignCare AI: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

AlignCare offers patient-chosen visit recording, Nora assistance, and Care Circle sharing. Patients can direct questions and sharing, but recipient-use restrictions limit care-partner advocacy. The terms give inconsistent descriptions of when invited recipients gain access.

Scope and agency posture

AlignCare's consumer visit-recording/Nora app and Care Circle sharing, operated by Frannaks Healthcare Advisory LLC. Patient-selected, vendor-hosted assistance. Caregiver access has separate conditions from the patient's own records.

Posture: Patient-directed visit assistance, with mixed care-partner control.

Axis: 82/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

• The homepage offers free recordings/transcripts and paid summaries, translation, and Nora. It describes revocable sharing and patient-set medication reminders.

• The August 27 terms, sections 5 and 10, recognize user-content ownership and granular sharing. Section 10 also forbids recipients using shared information to inform insurance, benefits, or legal-rights decisions. Approval-before-access language conflicts with a later passage saying attached records become visible on acceptance.

• The privacy policy, sections 5–7, excludes third-party foundation-model training and describes deletion timelines with exceptions. It does not name the AI providers in the reviewed passage.

Patient authority

Inference from the documented workflow: The patient controls questions, reminders, and sharing. Care Circle restrictions materially narrow what an authorized care partner may do with received information. Patient authorship and care-partner agency are not identical here.

Critical capacity

Editorial assessment: Original recordings and transcripts can support checking summaries. A care partner's ability to translate that understanding into benefits advocacy is limited by the stated use condition, even if the interface makes sharing easy.

Informed control

Editorial assessment: Training and deletion disclosures are more specific than the old report suggests. Conflicting invitation-access wording prevents a clear account of when disclosure starts. No claim is made about legal enforceability or actual implementation.

Assessment and limits

Documented control has improved, but the care-partner output-use restriction matters under the same standard used for other visit tools. Broadly positive caregiver-coordination wording is incomplete.

Confidence: Medium for terms, low for actual access enforcement.

Remaining uncertainty: Which invitation statement matches production, correction/export workflows, AI processor identities, and whether narrow caregiver-use terms are intended to exclude authorized appeal preparation.

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

• Reviewer/model: OpenAI Codex / GPT-6.
• Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
• Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
• Earlier review: 2026-06-08. Historical assessment. Earlier claims are not automatically reverified by this publication.